相关实验视频

Updated: Jul 17, 2025

Isolation of Double Negative αβ T Cells from the Kidney

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

在耐火性狼性炎中使用阿塔切普的经验

Emma Calatayud^1,2, Marco Montomoli³, Ana Ávila^4,5,6

¹Hospital Universitario Doctor Peset, Valencia, Spain. caem@alumni.uv.es.

Rheumatology international

|August 31, 2023

概括

阿巴cept可能为性炎患者提供安全的救援疗法,这些患者患有对其他治疗不耐药的性蛋白尿症. 这些病例显示完全缓解,没有严重的不良事件,表明其作为一个有价值的选择的潜力.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
类风湿病学类风湿病学
免疫学免疫学免疫学

背景情况:

狼性炎显著增加了系统性红斑狼患者的发病率.
有效的治疗对于预防慢性病进展至关重要.
新型疗法正在出现,但生物制剂在临床试验中显示出混合的结果.

研究的目的:

报告了两例狼性炎病例,这些病例已成功地用阿巴特塞普特治疗.
评估阿巴切作为耐火病例的救援疗法.
审查关于在狼性炎中使用阿巴切的文献.

主要方法:

两例狼性炎 (IV类) 病例报告耐受多种常规和生物疗法.
将阿巴塔塞普特添加到现有治疗方案中.
关于治疗狼性炎的阿巴切的文献综述.

主要成果:

两名患者在添加 abatacept 后实现了狼性炎与脏范围蛋白尿的完全缓解.
在 abatacept 治疗期间没有观察到任何严重的不良事件.
之前的生物疗法 (rituximab,belimumab,tocilizumab) 在一个案例中没有成功.

结论:

阿巴切可以成为耐火性狼性炎和性蛋白尿症患者的安全有效的救援疗法.
当其他疗法失败或无法耐受时,它提供了一个潜在的治疗选择.
需要进一步的研究来证实它在更大规模的研究中的有效性.

关键词:

这就是Abatacept.生物疗法是一种生物疗法.在 CTLA-4-Ig 中.狼性炎是一种神经炎.

更多相关视频

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

相关概念视频

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...